Vaccine-induced thrombosis and thrombocytopenia (VITT);Exploring the unknown
Journal of Family Medicine and Primary Care
; 11(5):2231-2233, 2022.
Article
in English
| Web of Science | ID: covidwho-2033310
ABSTRACT
Vaccination is supposed to be the most reliable means to end the COVID 19 pandemic, but recently there have been reports of thrombosis and thrombocytopenia in patients receiving the vaccine especially ChAdOx1 nCoV-19 (AstraZeneca University of Oxford and Serum Institute of India). This has been termed as vaccine-induced immune thrombotic thrombocytopenia (VITT), thrombosis with thrombocytopenia syndrome (ITS) and vaccine-induced prothrombotic immune thrombocytopenia (VIPIT). This is a challenging situation and patients are treated with Fondaparinaux and Rivaroxaban after thrombocytopenia is corrected. Herewith, we report a case of VITT who presented to our hospital and was successfully treated over a weeks' time.
Full text:
Available
Collection:
Databases of international organizations
Database:
Web of Science
Topics:
Vaccines
Language:
English
Journal:
Journal of Family Medicine and Primary Care
Year:
2022
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS